Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Indegene Limited is a life sciences commercialization company. It provides digital-led commercialization services for the life sciences industry.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Indegene Limited has informed the Exchange regarding a press release dated December 08, 2024, titled "Indegene Wins Deloitte Technology Fast 50 India 2024 Award in HealthTech ". | Download
Indegene Limited has informed the Exchange regarding a press release dated December 08, 2024, titled "Indegene Wins Deloitte Technology Fast 50 India 2024 Award in HealthTech ". | Download
Indegene Limited has informed the Exchange regarding 'Disclosure as per Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulation, 2015'. | Download
Indegene Limited has informed the Exchange regarding 'Disclosure as per Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulation, 2015'. | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant